Medifast Inc $MED Shares Sold by Prescott Group Capital Management L.L.C.

Prescott Group Capital Management L.L.C. trimmed its holdings in Medifast Inc (NYSE:MED) by 27.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 79,969 shares of the specialty retailer’s stock after selling 30,031 shares during the quarter. Prescott Group Capital Management L.L.C. owned approximately 0.73% of Medifast worth $1,124,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Nisa Investment Advisors LLC boosted its stake in Medifast by 370.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 2,144 shares of the specialty retailer’s stock worth $30,000 after purchasing an additional 1,688 shares during the period. Strs Ohio purchased a new stake in shares of Medifast in the first quarter valued at about $78,000. CWM LLC boosted its stake in shares of Medifast by 564.6% during the second quarter. CWM LLC now owns 7,457 shares of the specialty retailer’s stock worth $105,000 after buying an additional 6,335 shares during the period. Russell Investments Group Ltd. grew its holdings in shares of Medifast by 114.1% during the first quarter. Russell Investments Group Ltd. now owns 19,514 shares of the specialty retailer’s stock worth $267,000 after buying an additional 10,401 shares during the last quarter. Finally, Allianz Asset Management GmbH purchased a new position in shares of Medifast during the second quarter worth about $307,000. Hedge funds and other institutional investors own 95.51% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have commented on MED shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Medifast in a research note on Wednesday, October 8th. Wall Street Zen cut Medifast from a “hold” rating to a “sell” rating in a research note on Saturday. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and an average target price of $16.50.

Medifast Trading Up 1.3%

Shares of MED opened at $11.95 on Friday. The stock’s 50 day moving average is $13.35 and its two-hundred day moving average is $13.53. Medifast Inc has a twelve month low of $11.25 and a twelve month high of $21.98. The firm has a market capitalization of $131.34 million, a PE ratio of 37.34 and a beta of 0.82.

Medifast (NYSE:MED) last issued its earnings results on Monday, November 3rd. The specialty retailer reported ($0.21) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.20). Medifast had a return on equity of 2.00% and a net margin of 0.76%.The business had revenue of $89.41 million for the quarter, compared to analysts’ expectations of $84.10 million. Medifast has set its Q4 2025 guidance at -1.250–0.70 EPS. On average, sell-side analysts predict that Medifast Inc will post 0.51 EPS for the current year.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.